0
0
42 words
0
Comments
Earendil Labs raises $787M for AI drug platform, with 40+ programs and Sanofi partnership. CEO Jian Peng leads US-headquartered, China-rooted biotech considering Hong Kong IPO.
You are the first to view
https://endpoints.news/china-rooted-ai-biotech-earendil-labs-raises-787m-ahead-of-possible-ipo/
Create an account or login to join the discussion